EZH2 and bladder transitional cell carcinoma: It was manifested that miR-101 tends to inhibit cell proliferation by downregulating the expression of the enhancers of zeste homolog 2 (EZH2) in lung cancer [17], bladder transitional cell carcinoma [18] and embryonal rhabdomyosarcoma [19].